Healthcare >> Analyst Interviews >> May 29, 2000

Biotechnology Stocks : Kurt Von Emster – Franklin Advisers Inc

KURT VON EMSTER joined MPM Capital, LP, in November 2000 to extend their healthcare investment presence into the public markets. He is a General Partner of the MPM BioEquities Fund and manages several funds for MPM Advisors. He spent 11 years with Franklin Templeton Group as a Vice President and Portfolio Manager. At Franklin, Mr. von Emster managed over $2 billion in health and biotech funds, including the Franklin Biotechnology Discovery Fund and the Franklin Global Health Care Fund. Mr. von Emster holds the Chartered Financial Analyst designation, is a member of the Association for Investment Management and Research, and is a member of the Security Analysts of San Francisco. Mr. von Emster earned a degree from the University of California Santa Barbara in Business and Economics. Profile
TWST: What has been most striking about the performance of the

biotechnology stocks over the past six months or so?

Mr. von Emster: The immense volatility we've had is a bit of a surprise